Quick Answer
BioRestorative Therapies, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $359.7 thousand for the year ending 2025.
- BioRestorative Therapies, Inc. showed a decrease of -10.3% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from BioRestorative Therapies, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), BioRestorative Therapies, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 344.1%.
- Historical annual values: Fiscal year 2025: $359.7 thousand | Fiscal year 2024: $401.0 thousand | Fiscal year 2023: $145.8 thousand | Fiscal year 2022: $119.8 thousand | Fiscal year 2021: $46.0 thousand | Fiscal year 2020: $77.0 thousand | Fiscal year 2019: $130.0 thousand | Fiscal year 2018: $111.0 thousand | Fiscal year 2017: $81.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: